Form 4: Biogen Executive Rachid Izzar Reports Stock Transactions
SEC Form 4 Filing
Rachid Izzar, Head of Global Product Strategy at Biogen, reports the acquisition of shares through the vesting of restricted stock units and subsequent disposition to cover tax obligations.
Summary
- On February 10, 2025, Rachid Izzar, Head of Global Product Strategy at Biogen, reported transactions involving Biogen common stock.
- Izzar acquired 1,515 shares of common stock through the vesting of restricted stock units.
- Simultaneously, 445 shares were disposed of to cover tax obligations at a price of $142.54 per share.
- Following these transactions, Izzar directly owns 8,553 shares of Biogen common stock.
- The restricted stock units vest in three equal yearly installments beginning on February 10, 2022.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reflects routine stock transactions related to executive compensation and tax obligations.
Industry Context
Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their trading activities and beneficial ownership of company stock. This allows investors to monitor management's alignment with shareholder interests.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 02/10/2022 | Grant date of restricted stock units, vesting in three equal yearly installments. |
| 02/10/2025 | Date of stock acquisition through vesting of restricted stock units and disposition for tax obligations. |
| 02/12/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Biogen, BIIB, Rachid Izzar, Stock Transaction, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.